Библиографический список

1. Биохимия / Под ред. Е. С. Северина. М.: Гэотар-Мед, 2007.

2. Кулинский В. И. Обезвреживание ксенобиотиков // Соросовский образовательный журнал. 1999. № 1. С. 812.

3. Марри Р., Греннер Д., Мейес П., Родуэл В. Биохимия человека. М.: Мир, 2004. Т. 12.

4. Овчинников Ю. А. Биоорганическая химия. М.: Просвещение, 1987.

5. Страйер Л. Биохимия. М.: Мир, 1984. Т. 13.

6. Alderton W. K., Cooper C. E., Knowles R. G. Nitric oxide synthases: structure, function and inhibition // Biochem. J. 2001. Vol. 357. P. 593615.

7. Barclay A. N. Ig-like domains: evolution from simple interaction molecules to sophisticated antigen recognition // Proc. Natl. Acad. Sci. U S A. 1999. Vol. 96. P. 1467214674.

8. Сole J. L. Activation of PKR: an open and shut case? // Trends Biochem. Sci. 2006. Vol. 32. P. 5762.

9. Cole S. P. C., Deeley R. G. Transport of glutathione and glutathione conjugates by MRP1 // Trends Pharmacol. Sci. 2006. Vol. 27. P. 438446

10. Deeley R. G., Westlake C., Cole S. P. C. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multi-drug resistance proteins // Physiol. Rev. 2006. Vol. 86. P. 849–899.

11. Dey M., Cao C., Dar A. C., Tamura T., Ozato K., Sicheri F., Dever T. E. Mechanistic link between PKR dimerization, autophosphorylation, and eIF2 substrate recognition // Cell. 2005. Vol. 122. P. 901–913.

12. Dong B., Niwa M., Walter P., Silverman R. H. Basis for regulated RNA cleavage by functional analysis of RNase L and Ire1p // RNA. 2001. Vol. 7. P. 361–373.

13. Fritz-Wolf K., Becker A., Rahl S., Harwaldt P., Schirmer R. H., Kabsch W., Becker K. X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum // Proc. Natl. Acad. Sci. U.S.A. 2003. Vol. 100. P. 13821–13826.

14. Gamage N. U., Tsvetanov S., Duggleby R. G., McManus M. E., Martin J. L. The structure of human SULT1A1 crystallized with estradiol. An insight into active site plasticity and substrate inhibition with multi-ring substrates // J. Biol. Chem. 2005.Vol. 280. P. 41482–41486.

15. Gantier M. P., Williams B. R. G. The response of mammalian cells to double-stranded RNA // Cytokine Growth Factor Rev. 2007. Vol. 18. P. 363–371.

16. Haan С., Kreis S., Margue C., Behrmann I.. Jaks and cytokine receptors. An intimate relationship // Biochem. Pharmacol. 2006. Vol. 72. P. 1538–1546.

17. Hartmann R., Justesen J., Sarkar S. N., Sen G. S.,. Yee V. C. Crystal structure of the 2’-specific and double-stranded RNA-activated inteferon-induced antiviral protein 2’-5’-oligoadenylate synthetase // Mol. Cell. 2003. Vol. 19. P. 1173–1185.

18. http:// humbio.ru/humbio/histology

19. Kisseleva T., Bhattacharya S., Braunstein J., Schindler C. W. Signaling through the JAK/STAT pathway, recent advances and future challenges // Gene. 2002. Vol. 285. P. 1–24.

20. Kосhs G., Haller O. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids // Proc. Natl. Acad. Sci. 1999. Vol. 96. P. 2082–2086.

21. Li H., Gade P., Xiao W., Kalvakolanu D. V. The interferon signaling network and transcription factor C/EBP-β // Cell. Mol. Immunol. 2007. Vol. 4. P. 407−418.

22. Li X., Leung S., Kerr I. M., Stark G. R. Functional subdomains of STAT2 required for preassociation with the -Interferon receptor and for signaling // Mol. Cell. Biol. 1997. Vol. 17. P. 2048–2056.

23. Miley M. J., Zielinska A. K., Keenan J. E., Bratton S. M., Radominska-Pandya A., Redinbo M. R. Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucurono-syltransferase 2B7 // J. Mol. Biol. 2007. Vol. 369. P. 498–511.

24. Nakanishi M., Goto Y., Kitade Y. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L // Proteins. 2005. Vol. 60. P. 131–138.

25. Samuel C. E. Antiviral actions of interferons // Clin. Microbiol. Rev. 2001. Vol. 14. P. 778–809

26. Sarkar S. N., Sen G. C. Novel functions of proteins encoded by viral stress-inducible genes // Pharmacol. Ther. 2004. Vol. 103. P. 245– 259.

27. Schindler С., Levy D. E., Decker T. JAK-STAT signaling: from interferons to cytokines // J. Biol. Chem. 2007. Vol. 282. P. 20059 20063.

28. Tanaka N., Nakanishi M., Kusakabe Y., Goto Y., Kitade Y., Nakamura K. T. Structural basis for recognition of 2’,5’-linked oligoadenylates by human ribonuclease L // EMBO J. 2004. Vol. 23. P. 3929–3938.

29. Testa B., Kraemer S. D. The biochemistry of drug metabolism – An introduction. Part 2. Redox reactions and their enzymes // Chem. Biodivers. 2007. Vol. 4. P. 257405.

30. Yoshinari K., Petrotchenko E. V., Pedersen L. C., Negishi M. Crystal structure-based studies of cytosolic sulfotransferase // J. Biochem. Mol. Toxicol. 2001. Vol. 15. P. 67–75.

31. Zhang X., Hua Y., Yuan Z. Computational analyses of JAK1 kinase domain: Subtle changes in the catalytic cleft influence inhibitor specificity // Biochem. Biophys. Res. Commun. 2008. Vol. 370. P. 72–76.

32. Zhang Z., Devarajan P., Dorfman A. L., Morrow J. S. Structure of the ankyrin-binding domain of -Na,K-ATPase // J. Biol. Chem. 1998. Vol. 273. P. 18681–18684.

99